Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

PLX, a tomato extract mix, may help treat prostate issues like BPH.

Trypsin slows hair growth and affects color by causing cell death in hair follicles.

The new controlled release PRP therapy shows promise for hair growth in women.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

Pueraria thunbergiana extract may help prevent hair from turning gray.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Some drugs for inflammation may cause psoriasis-like hair loss.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.